Overview

Pharmacokinetic Study of Dexmedetomidine After Intra-Nasal and Buccal Dosing in Children

Status:
Recruiting
Trial end date:
2021-12-30
Target enrollment:
Participant gender:
Summary
This research study is a continuation of a previous DEX PK study. It is examining the absorption of Dexmedetomidine (DEX) in the blood when given orally and as a nasal spray. This study will help us determine the best dosing amount for children undergoing sedation or anesthesia with DEX.
Phase:
Phase 1
Details
Lead Sponsor:
Children's Hospital Medical Center, Cincinnati
Treatments:
Dexmedetomidine